DK173590D0 - Rekombinante terapeutiske lipaser - Google Patents

Rekombinante terapeutiske lipaser

Info

Publication number
DK173590D0
DK173590D0 DK173590A DK173590A DK173590D0 DK 173590 D0 DK173590 D0 DK 173590D0 DK 173590 A DK173590 A DK 173590A DK 173590 A DK173590 A DK 173590A DK 173590 D0 DK173590 D0 DK 173590D0
Authority
DK
Denmark
Prior art keywords
lipases
recombinant therapeutic
lipase
prophylaxis
mammals
Prior art date
Application number
DK173590A
Other languages
English (en)
Inventor
Birgitte Huge-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK137990A external-priority patent/DK137990D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK173590A priority Critical patent/DK173590D0/da
Publication of DK173590D0 publication Critical patent/DK173590D0/da
Priority to AU80964/91A priority patent/AU645583B2/en
Priority to JP03510710A priority patent/JP3072853B2/ja
Priority to AT91910966T priority patent/ATE178492T1/de
Priority to PCT/DK1991/000149 priority patent/WO1991018623A1/en
Priority to EP91910966A priority patent/EP0600868B1/en
Priority to FI925530A priority patent/FI925530L/fi
Priority to DE69131106T priority patent/DE69131106T2/de
Priority to CA002084184A priority patent/CA2084184A1/en
Priority to US08/318,036 priority patent/US5614189A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK173590A 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser DK173590D0 (da)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser
CA002084184A CA2084184A1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
DE69131106T DE69131106T2 (de) 1990-06-06 1991-06-04 Gentechnologisch hergestellte lipasen für die therapeutische behandlung
AT91910966T ATE178492T1 (de) 1990-06-06 1991-06-04 Gentechnologisch hergestellte lipasen für die therapeutische behandlung
JP03510710A JP3072853B2 (ja) 1990-06-06 1991-06-04 治療用に、組換方法で生産されたリパーゼ
AU80964/91A AU645583B2 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
PCT/DK1991/000149 WO1991018623A1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
EP91910966A EP0600868B1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
FI925530A FI925530L (fi) 1990-06-06 1991-06-04 Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk
US08/318,036 US5614189A (en) 1990-06-06 1994-10-04 Recombinantly produced lipases for therapeutical treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK137990A DK137990D0 (da) 1990-06-06 1990-06-06 Rekombinante terapeutiske lipaser
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser

Publications (1)

Publication Number Publication Date
DK173590D0 true DK173590D0 (da) 1990-07-19

Family

ID=26065679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser

Country Status (10)

Country Link
US (1) US5614189A (da)
EP (1) EP0600868B1 (da)
JP (1) JP3072853B2 (da)
AT (1) ATE178492T1 (da)
AU (1) AU645583B2 (da)
CA (1) CA2084184A1 (da)
DE (1) DE69131106T2 (da)
DK (1) DK173590D0 (da)
FI (1) FI925530L (da)
WO (1) WO1991018623A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
ES2314646T3 (es) 2004-03-22 2009-03-16 Solvay Pharmaceuticals Gmbh Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos.
CA2586222A1 (en) 2004-05-24 2005-12-08 Novozymes A/S Enzymes for pharmaceutical use
SI1809320T1 (sl) 2004-10-14 2010-11-30 Cystic Fibrosis Foundation Therapeutics Inc Sestavki ki vsebujejo lipazo proteazo in amilazo za zdravljenje pankreasne insuficience
AU2006261443A1 (en) * 2005-06-24 2006-12-28 Novozymes A/S Proteases for pharmaceutical use
EP1896057A2 (en) 2005-06-24 2008-03-12 Novozymes A/S Amylases for pharmaceutical use
US20090047266A1 (en) * 2005-06-24 2009-02-19 Novozymes A/S Lipases for Pharmaceutical Use
HUE031042T2 (en) * 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
WO2007053619A2 (en) 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US8273348B2 (en) 2006-12-21 2012-09-25 Novozymes A/S Lipase variants for pharmaceutical use
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
CN101889084A (zh) * 2007-12-04 2010-11-17 诺维信公司 供药学应用的蛋白酶变体
MX2010007242A (es) * 2008-01-03 2010-10-05 Abbott Products Gmbh Composiciones farmaceuticas que comprenden granulos de lipasa microbiana purificada y metodos para prevenir o tratar trastornos digestivos.
WO2010085975A1 (de) * 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches präparat enthaltend lipase bakteriellen ursprungs
WO2011000924A1 (en) 2009-07-03 2011-01-06 Abbott Products Gmbh Spray-dried amylase, pharmaceutical preparations comprising the same and use
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
US20160152968A1 (en) * 2013-07-22 2016-06-02 Aptalis Pharma Ltd. High potency pancreatin pharmaceutical compositions
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114857A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition
US4659667A (en) * 1985-02-26 1987-04-21 Miles Laboratories, Inc. Process to recover crystalline enzymes and crystalline enzymes produced thereby
US5108457A (en) * 1986-11-19 1992-04-28 The Clorox Company Enzymatic peracid bleaching system with modified enzyme
DE3854249T2 (de) * 1987-08-28 1996-02-29 Novonordisk As Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen.
EP0506791B1 (en) * 1989-12-21 1993-09-08 Novo Nordisk A/S Enzyme containing preparation and detergent containing such preparation

Also Published As

Publication number Publication date
JPH06501147A (ja) 1994-02-10
FI925530A0 (fi) 1992-12-04
ATE178492T1 (de) 1999-04-15
CA2084184A1 (en) 1991-12-07
WO1991018623A1 (en) 1991-12-12
DE69131106T2 (de) 1999-11-18
AU645583B2 (en) 1994-01-20
EP0600868B1 (en) 1999-04-07
FI925530A7 (fi) 1992-12-04
DE69131106D1 (de) 1999-05-12
AU8096491A (en) 1991-12-31
EP0600868A1 (en) 1994-06-15
FI925530L (fi) 1992-12-04
JP3072853B2 (ja) 2000-08-07
US5614189A (en) 1997-03-25

Similar Documents

Publication Publication Date Title
FI925530A0 (fi) Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
MY101842A (en) Treatment of oral diseases.
ES2007625A6 (es) Un procedimiento para la produccion de una proteina para huesos y cartilagos.
DK0611522T3 (da) Synergistiske mikrobicide sammensætninger
TW262461B (da)
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
AU563748B2 (en) Quinolone carboxylic acids
PT764167E (pt) Inibidor biciclico de lactama do enzima de conversao da beta-interleucina-1
DE69520364D1 (de) Benzothepines mit wirkung als inhibitoren des gallensäuretransports und der taurocholate-aufnahme
JPS5799576A (en) 3-(p-alkylsulfonylphenyl)oxazolidinone derivatives
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
IL64885A (en) 3,20-dioxo-1,4-pregnadiene-17alpha-ol-17-aromatic heterocyclic esters,their preparation and pharmaceutical compositions containing them
PL321848A1 (en) Cell adhesion inhibitors
MY117526A (en) N-(3-benzofuranyl)urea-derivatives
AP9100310A0 (en) Tnf inhibitors
CA2267932A1 (en) Compositions for postgastrectomic mineral supply
DE69432573D1 (de) Inhibitoren des Endothelin konvertierenden Enzyms
NO171634C (no) Analogifremgangsmaate for fremstilling av alfa-aryl-4-(4,5-dihydro-3,5-diokso-1,2,4-triazin-2(3h)-yl)-benzenacetonitriler
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
FI970203A0 (fi) Pyridyylitioyhdisteet helikobakteerien torjumiseksi
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
NO177055C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner
GR3015470T3 (en) Inhibitors of lysyl oxidase.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)
PUP Patent expired